700 related articles for article (PubMed ID: 23864535)
1. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
Todd KL; Wright DI;
Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
King JT; O'Byrne M; Vasquez M; Wright D;
Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
[TBL] [Abstract][Full Text] [Related]
3. Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2).
Todd KL; Wright DI;
J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):258-264.e1. PubMed ID: 26992303
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities.
Vasquez M; Gasparis AP;
Phlebology; 2017 May; 32(4):272-281. PubMed ID: 26957489
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
Gibson K; Kabnick L;
Phlebology; 2017 Apr; 32(3):185-193. PubMed ID: 27013511
[TBL] [Abstract][Full Text] [Related]
6. Endovenous microfoam ablation of below knee superficial truncal veins is safe and effective in patients with prior saphenous treatment across a wide range of CEAP classes.
Jimenez JC; Lawrence PF; Pavlyha M; Farley SM; Rigberg DA; DeRubertis BG; Woo K;
J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):390-394. PubMed ID: 34474174
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries.
Jimenez JC; Lawrence PF; Woo K; Chun TT; Farley SM; Rigberg DA; Baril DT; Derubertis BG
J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):904-909. PubMed ID: 33248297
[TBL] [Abstract][Full Text] [Related]
8. Results of polidocanol endovenous microfoam in clinical practice.
Kim PS; Elias S; Gasparis A; Labropoulos N
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):122-127. PubMed ID: 32353594
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.
Regan JD; Gibson KD; Rush JE; Shortell CK; Hirsch SA; Wright DD
J Vasc Surg; 2011 Jan; 53(1):131-7. PubMed ID: 20864303
[TBL] [Abstract][Full Text] [Related]
10. Retrograde administration of ultrasound-guided endovenous microfoam chemical ablation for the treatment of superficial venous insufficiency.
Deak ST
J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):477-484. PubMed ID: 29909854
[TBL] [Abstract][Full Text] [Related]
11. Relationship between patient-reported symptoms, limitations in daily activities, and psychological impact in varicose veins.
Mallick R; Lal BK; Daugherty C
J Vasc Surg Venous Lymphat Disord; 2017 Mar; 5(2):224-237. PubMed ID: 28214491
[TBL] [Abstract][Full Text] [Related]
12. Use of Polidocanol Endovenous Microfoam to Improve Hemodynamics and Symptomology in Patients with Challenging Clinical Presentations: A Case Series.
Davis PE; Phillips J; Kolluri R
Ann Vasc Surg; 2018 Oct; 52():176-182. PubMed ID: 29772321
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
Rabe E; Otto J; Schliephake D; Pannier F
Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
[TBL] [Abstract][Full Text] [Related]
14. Polidocanol for endovenous microfoam sclerosant therapy.
Eckmann DM
Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
[TBL] [Abstract][Full Text] [Related]
15. Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.
Wright DD; Paty J; Turner-Bowker DM; Bradbury A
Patient; 2016 Aug; 9(4):335-48. PubMed ID: 27016239
[TBL] [Abstract][Full Text] [Related]
16. Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures.
King T; Coulomb G; Goldman A; Sheen V; McWilliams S; Guptan RC
Int Angiol; 2009 Aug; 28(4):289-97. PubMed ID: 19648872
[TBL] [Abstract][Full Text] [Related]
17. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of right-to-left shunt in patients with symptomatic great saphenous incompetence and varicose veins.
Wright DD; Gibson KD; Barclay J; Razumovsky A; Rush J; McCollum CN
J Vasc Surg; 2010 Jan; 51(1):104-7. PubMed ID: 19837542
[TBL] [Abstract][Full Text] [Related]
19. Microfoam sclerotherapy.
Redondo P; Cabrera J
Semin Cutan Med Surg; 2005 Dec; 24(4):175-83. PubMed ID: 16387261
[TBL] [Abstract][Full Text] [Related]
20. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up.
Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA
Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
